After topping the Street's expectations with its Q3 earnings, Cipla announced plans to launch two key drugs in FY26—the respiratory drug Advair and the oncology drug Abraxane. Umang Vohra ...

21 in Wisconsin federal court. Schmidtknecht took daily doses of Advair Diskus to manage his asthma, the lawsuit said. His medication was covered by his employer-provided health insurance United ...

Bunnings may be a goldmine for Wesfarmers, but ecommerce site Catch has been a millstone since the ASX-listed retail conglomerate bought the tech startup for $230 million in 2019. Today, Wesfarmers ...

While Sandoz has emerged as the front-runner to get a generic version of GlaxoSmithKline’s respiratory blockbuster Advair to the US market, rival Hikma has not given up despite a major setback.

GlaxoSmithKline’s ageing respiratory blockbuster Advair has been living a charmed life since going off patent years ago - but as yet no-one has been able to get a generic rival approved in the ...